| Hans-Günter Meyer-Thompson | Hepatitiden
High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units.
High rates of early HCV reinfection after DAA treatment in people with recent drug use attended at mobile harm reduction units.
Valencia J, Alvaro-Meca A, Troya J, Cuevas G, Gutiérrez J, Morro A, Alvarez J, Pulido L, Cañamares I, Escobar I, Moreno S, Ryan P.
Int J Drug Policy. 2019 Jun 25. pii: S0955-3959(19)30171-9. doi: 10.1016/j.drugpo.2019.06.016.
Abstract